HR Execs on the Move

Graybug Vision

www.graybug.vision

 
Every day, Graybug Vision works relentlessly to make healthy vision more accessible and more manageable for patients with chronic vision-threatening eye diseases. We are a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve. Our novel technologies are designed to release drugs in ocular tissue at a controlled rate for up to 12 months in order to improve patient compliance, reduce healthcare burdens and, ultimately, deliver better clinical outcomes.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.graybug.vision
  • 275 Shoreline Drive Suite 450
    Redwood City, CA USA 94065
  • Phone: 650.487.2800

Executives

Name Title Contact Details
Bettina Maunz
Chief People Officer Profile

Similar Companies

Gandara Center

Gándara was established in 1977 by a doctor named Jose Gándara, of Puerto Rican descent who sought to provide mental health services to the growing and largely Hispanic community in Holyoke, Massachusetts. Recently the Gándara Center expanded services ...

Xpress Wellness Urgent Care

Xpress Wellness provides urgent care, primary care, and occupational medicine. Walk in, check in online, or schedule a virtual visit today.

Milestone Pharmaceuticals

Milestone was founded in 2005 with the underlying concept to base its drug development programs on clinically validated mechanisms of action in order to mitigate as much drug development risk as possible. The company has raised a total of $34 million in venture capital financing since 2006. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. The drug hunters proposed NCE projects based on clinically proven science to form the basis of Milestone’s drug development programs. Milestone has a seasoned management team with experience in cardiovascular diseases, drug development and business start-ups as well as world-class advisory boards of key opinion leaders with significant expertise in cardiology, regulatory affairs, as well as formulation and drug development.

CDx Diagnostics

The developer of advanced diagnostic tests that empower physicians to preempt cancer, including WATS3D, for increased detection of Barrett`s esophagus and dysplasia.